ORKA: HC Wainwright Reiterates Buy
HC Wainwright & Co. reiterates buy rating on Oruka Therapeutics and maintains $120 price target
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.